HIV

Peer-based health advocacy for patients living with HIV can be received differently and affect HIV protective behavior based on gender dynamics and relationship type.

Legislation that could change the 340B program should be done so with caution, as the federal program acts as a boon to care for patients with HIV, experts argue.

For the third episode in our special Pride Month series, we speak with Patrick McGovern, CEO of Callen-Lorde since August of 2023 and an outspoken advocate for HIV; lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+); and community health.

Ageing with HIV comes with greater risks of other health complications; behavioral counseling programs for obesity are scare and often not covered by insurance; the surgeon general is calling for legislative action to protect youth when they interact with social media.

New blood donation eligibility guidelines affecting men who have sex with men (MSM) could slightly increase rates of deferring blood donation, according a model that assessed an individual risk-based deferral policy.

Patients with HIV who were more impacted by health disparities were less likely to find long-acting injectable antiretroviral therapy appealing.

Young and educated men who have sex with men (MSM) were more likely to use self-testing for HIV.

Patients in dental settings had a comparable uptake of point-of-care HIV tests when compared with non-specialized health settings.

Men who have sex with men (MSM) who have HIV and were in a marriage of convenience were found to have an increased risk of experiencing intimate partner violence.

Women who used a dolutegravir-based regimen had less mother-to-infant transmission of HIV compared with those on efavirenz-based regimens.

Patients with HIV who switched to a treatment regimen that included tenofovir alafenamide (TAF) showed improvement in serum markers for hepatic steatosis (HS) among other benefits.

Youth without HIV had a longer life expectancy compared with youth with HIV when using a microsimulation modeling analysis.

Earlier antiretroviral therapy was found to be safe in regards to kidney health, with benefits of virologic suppression and immune reconstitution.

A high burden of HIV could indicate other underlying factors, such as limited access to health care resources and a risk of major depressive disorder.

Dr William R Short discusses how clinical trials and treatment by a doctor should change with new treatment available and needed.

Lower rates of cardiac surgery were found in patients living with HIV along with an increased risk of adverse events.

William R. Short, MD, MPH, of the University of Pennsylvania, discusses how a label update for bictegravir can help provide safe and effective HIV treatment for pregnant people.

Asian men who have sex with men (MSM) who recently immigrated to Australia were found to have lower uptake of pre-exposure prophylaxis (PrEP).

Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.

Men who have sex with men (MSM) who are HIV-negative reported interest in an injectable pre-exposure prophylaxis (PrEP) that lasted longer than the daily pill, regardless of cost or coverage.

A new study found that dentists were lacking in experience when it came to dental aspects of HIV infection.

HIV testing uptake was improved in immigrants after peer interventions with multiple strategies were implemented.

Pregnant women with HIV need targeted interventions and improved care to combat these adverse outcomes.

HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.

A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV.